NCT00006487 arm group c5b6276442e5cd156075cb62815c59e8 [clinicaltrials_resource:NCT00006487/arm-group/c5b6276442e5cd156075cb62815c59e8]
cisplatin [clinicaltrials_resource:5ab8cb76bd3bb193a0e55cb62506ffc9]etoposide [clinicaltrials_resource:7b54f55fd5ba6135e29a29b6aef11a39]radiation therapy [clinicaltrials_resource:adf254baa2698572797c1eae64d04c15]tirapazamine [clinicaltrials_resource:d73681011bd90c6a53615d759a523010]clinicaltrials:NCT00006487
arm group [clinicaltrials_vocabulary:arm-group]
NCT00006487 arm group c5b6276442e5cd156075cb62815c59e8 [clinicaltrials_resource:NCT00006487/arm-group/c5b6276442e5cd156075cb62815c59e8]
Bio2RDF identifier
NCT00006487/arm-group/c5b6276442e5cd156075cb62815c59e8
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... b6276442e5cd156075cb62815c59e8
description [clinicaltrials_vocabulary:description]
induction and consolidation: cisplatin, etoposide, tirapazamine, radiation therapy
identifier
clinicaltrials_resource:NCT00006487/arm-group/c5b6276442e5cd156075cb62815c59e8
title
NCT00006487 arm group c5b6276442e5cd156075cb62815c59e8
@en
type
label
NCT00006487 arm group c5b62764 ...... 6276442e5cd156075cb62815c59e8]
@en